Research

Dr. Mohapatra has authored multiple peer-reviewed papers focusing on hematological malignancies, biomarkers, and stem cell therapies. She actively participates in national and international conferences including HAEMATOCON.

  • Mohapatra S, Mourad YRA, Cherniawsky HM, Chung SS, Forrest DL, Kaila G, et al. Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years. Transplantation and Cellular Therapy. 2025 Feb;31(2):550-1.
    https://doi.org/10.31547/bct-2025-001.
  • Mohapatra, S., Das, P.K., Mahapatra, A. et al. A Prospective Observational Study of the Prognostic Role of Procalcitonin Compared with High Sensitivity C Reactive Protein in Patients ≥ 15Years of Age with Acute Lymphoblastic Leukemia/Lymphoma with Febrile Neutropenia. Indian J Hematol Blood Transfus (2024).
    https://doi.org/10.1007/s12288-024-01832-9.
  • Mohapatra, S., Das, P.K., Rao, P.B. et al. Rescue splenic artery embolization in an adult patient of sickle cell disease presented with acute splenic sequestration crisis. Emerg Radiol 31, 613-617 (2024).
    https://doi.org/10.1007/s10140-024-02246-w.
  • Mohapatra S, Padhi S, Das PK, Chhabra G. Myelodysplastic Syndrome with Excess Blasts and Erythroid Predominance (MDS-EB-E) With NPM1 Mutation and P53 Expression. Ann Hematol Onco. 2023; 10(6): 1440.